Chemical industry – Page 57
-
FeaturePersonalised skincare
Nina Notman explores some of the latest scientific approaches skincare companies are using in the quest to develop high-earning anti-ageing cosmetics
-
OpinionUncertainty around Trump presidency is harmful to industry
Uncertainty is anathema to industry. Trump and Brexit are frustrations, but the wheels do not stop.
-
BusinessAmmonia leak leads to fatality at UK brewery
One dead and 22 hospitalised after accident at Carlsberg site
-
NewsTrump’s election sparks anxiety among scientists
Research community fears a Trump presidency will harm US science, but the biotech and pharma industry are more upbeat
-
BusinessUS extends permission for combination pesticide
EPA finds no synergy concerns with Dow’s Enlist Duo and reverses restrictions on its approval
-
NewsChemical industry applauds passage of EU–Canada trade deal
Long-awaited Ceta free trade agreement will be good news for the chemical industry in both regions
-
BusinessLinde to cut costs and jobs
German industrial gas giant to restructure to save €550 million a year from 2019
-
OpinionRegulatory tightropes
When lobbying and marketing clash with scientific evidence, regulators walk a fine line
-
OpinionPutting chemistry back in biology
The chemical nature of biomolecular interactions can no longer be ignored
-
BusinessEU scrutinises Syngenta–ChemChina union
European commission investigates competition concerns in agricultural megamerger
-
BusinessA match made in medicine
Technology companies have begun to turn their resources towards health research. Is it just hype or can big tech bring something new?
-
NewsMOFs offer safer toxic gas storage
Start-up’s gas cylinders allows sub-atmospheric storage of hazardous gases like arsine used in semiconductor processing
-
BusinessCorn growers’ lawsuit contested by Syngenta
Syngenta opposes class action seeking over $5bn in damages related to its genetically engineered corn
-
BusinessBoost for carbon capture projects in India, Norway and Australia
New projects unveiled, as UK carbon capture policy is criticised
-
BusinessSC Johnson revisits its use of galaxolide
Concerns of environmental and health groups leads firm to review scientific data on the fragrance chemical
-
FeatureSmarter smells
After years of research, the flavour and fragrance industry is increasingly turning to biotechnology for commercial production, as Emma Davies reports
-
BusinessAstraZeneca sheds multiple drugs
Spate of licensing deals for non-core products as firm further tightens R&D focus
-
NewsPfizer launches new biosimilar drug in US
Autoimmune disease treatment becomes only the second biosimilar to be approved by the FDA
-
BusinessThird fatality confirmed in BASF incident
Crackers and related plants will restart over coming days
-
PodcastGabapentin
Louise Crane documents the rise and fall of Gabapentin – from ‘wonder drug’ to illicit substance in just 50 years